Midazolam

Midazolam is an imidazobenzodiazepine that is 4H-imidazo[1,5-a][1,4]benzodiazepine that is substituted by a methyl, 2-fluorophenyl and chloro groups at positions 1, 6 and 8, respectively. Among its listed roles, it functions as a GABAA receptor agonist, an anticonvulsant, an anxiolytic drug, an apoptosis inducer, an antineoplastic agent, a muscle relaxant, a sedative, a general anaesthetic and a central nervous system depressant. It is an organochlorine compound, an imidazobenzodiazepine and a member of monofluorobenzenes. It is grouped under the following drug class(es): Benzodiazepines, Controlled drug substances, Neurotransmitter agents, Psychotropic agents, Schedule IV controlled substances and Sedatives. Its therapeutic use is listed as antianxiety drugs, central nervous system (CNS) agents and veterinary tranquilizers. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Buccolam, Nayzilam, mezolam and Epistatus. It is listed as a controlled drug substance (Schedule IV). Its PubChem CID is 4192.